IFP Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $145K | Sell |
2,936
-796
| -21% | -$40.4K | ﹤0.01% | 1733 |
|
|
2026
Q1 | $199K | Buy |
3,732
+203
| +6% | +$11.9K | ﹤0.01% | 1407 |
|
|
2025
Q4 | $219K | Buy |
3,529
+252
| +8% | +$15.6K | ﹤0.01% | 1329 |
|
|
2025
Q3 | $197K | Sell |
3,277
-10
| -0.3% | -$612 | 0.01% | 1298 |
|
|
2025
Q2 | $206K | Buy |
3,287
+58
| +2% | +$3.48K | 0.01% | 1260 |
|
|
2025
Q1 | $194K | Sell |
3,229
-1,736
| -35% | -$108K | 0.01% | 1189 |
|
|
2024
Q4 | $290K | Sell |
4,965
-102
| -2% | -$6.06K | 0.01% | 958 |
|
|
2024
Q3 | $300K | Sell |
5,067
-4,980
| -50% | -$284K | 0.01% | 895 |
|
|
2024
Q2 | $563K | Sell |
10,047
-178
| -2% | -$9.96K | 0.02% | 618 |
|
|
2024
Q1 | $599K | Sell |
10,225
-7,331
| -42% | -$414K | 0.03% | 557 |
|
|
2023
Q4 | $948K | Sell |
17,556
-1,273
| -7% | -$62.2K | 0.04% | 396 |
|
|
2023
Q3 | $913K | Buy |
18,829
+112
| +0.6% | +$5.96K | 0.04% | 415 |
|
|
2023
Q2 | $1.06M | Sell |
18,717
-5,183
| -22% | -$285K | 0.04% | 413 |
|
|
2023
Q1 | $4.79M | Sell |
23,900
-66,927
| -74% | -$3.56M | 0.21% | 94 |
|
|
2022
Q4 | $18.2M | Sell |
90,827
-12,709
| -12% | -$645K | 0.49% | 27 |
|
|
2022
Q3 | $20.7M | Buy |
103,536
+1,905
| +2% | +$98.8K | 0.54% | 24 |
|
|
2022
Q2 | $20.4M | Hold |
101,631
| – | – | 0.65% | 15 |
|
|
2022
Q1 | $20.4M | Buy |
101,631
+74,400
| +273% | +$4.44M | 0.65% | 15 |
|
|
2021
Q4 | $1.8M | Buy |
27,231
+11,070
| +68% | +$709K | 0.04% | 297 |
|
|
2021
Q3 | $1.02M | Buy |
16,161
+2,565
| +19% | +$164K | 0.02% | 398 |
|
|
2021
Q2 | $817K | Sell |
13,596
-5,286
| -28% | -$306K | 0.02% | 417 |
|
|
2021
Q1 | $1.04M | Sell |
18,882
-17,172
| -48% | -$952K | 0.02% | 356 |
|
|
2020
Q4 | $1.97M | Buy |
36,054
+10,728
| +42% | +$561K | 0.08% | 210 |
|
|
2020
Q3 | $1.27M | Buy |
25,326
+5,106
| +25% | +$247K | 0.08% | 245 |
|
|
2020
Q2 | $874K | Buy |
20,220
+13,530
| +202% | +$578K | 0.07% | 299 |
|
|
2020
Q1 | $247K | Sell |
6,690
-16,656
| -71% | -$701K | 0.02% | 513 |
|
|
2019
Q4 | $1.04M | Sell |
23,346
-35,340
| -60% | -$1.49M | 0.08% | 271 |
|
|
2019
Q3 | $2.38M | Buy |
+58,686
| New | +$2.4M | 0.16% | 144 |
|
|
2019
Q1 | $930K | Sell |
24,222
-47,736
| -66% | -$1.73M | 0.13% | 173 |
|
|
2018
Q4 | $2.36M | Buy |
71,958
+1,410
| +2% | +$48.8K | 0.14% | 161 |
|
|
2018
Q3 | $2.67M | Buy |
70,548
+15,510
| +28% | +$551K | 0.11% | 205 |
|
|
2018
Q2 | $1.84M | Buy |
55,038
+7,344
| +15% | +$239K | 0.08% | 266 |
|
|
2018
Q1 | $1.38M | Hold |
47,694
| – | – | 0.06% | 310 |
|
|
2017
Q4 | $1.38M | Sell |
47,694
-1,404
| -3% | -$40.5K | 0.06% | 311 |
|
|
2017
Q3 | $1.37M | Sell |
49,098
-72,780
| -60% | -$2.01M | 0.05% | 355 |
|
|
2017
Q2 | $3.38M | Sell |
121,878
-49,692
| -29% | -$1.32M | 0.14% | 164 |
|
|
2017
Q1 | $4.33M | Buy |
171,570
+4,176
| +2% | +$101K | 0.19% | 114 |
|
|
2016
Q4 | $3.71M | Buy |
167,394
+107,040
| +177% | +$2.43M | 0.18% | 130 |
|
|
2016
Q3 | $1.46M | Sell |
60,354
-3,690
| -6% | -$87.8K | 0.08% | 274 |
|
|
2016
Q2 | $1.45M | Buy |
64,044
+39,822
| +164% | +$862K | 0.08% | 270 |
|
|
2016
Q1 | $930K | Sell |
24,222
-36,078
| -60% | -$701K | 0.13% | 173 |
|
|
2015
Q4 | $1.23M | Buy |
+60,300
| New | +$1.21M | 0.08% | 260 |
|
Other funds holding IHI
AAS
IFP Advisors's IHI Position: Q2 2026 in Review
IFP Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 21% in Q2 2026, selling an estimated $40.4K and leaving 2,936 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1733.
IFP Advisors first reported a position in IHI in Q4 2015 and has held it in 42 quarters since. The position peaked at $20.7M in Q3 2022. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- IFP Advisors held 2,936 shares of iShares US Medical Devices ETF worth $145K as of Q2 2026.
- IFP Advisors sold 796 iShares US Medical Devices ETF shares in Q2 2026, an estimated $40.4K.
- iShares US Medical Devices ETF made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1733 holding.
- IFP Advisors first reported a position in iShares US Medical Devices ETF in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's iShares US Medical Devices ETF position peaked at $20.7M in Q3 2022.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.